Osteosarcoma-enriched transcripts paradoxically generate osteosarcoma-suppressing extracellular proteins

Kexin Li1,2, Qingji Huo1,2, Nathan H Dimmitt2

  • 1Department of Pharmacology, School of Pharmacy, Harbin Medical University, Harbin, China.

Elife
|March 21, 2023
PubMed

Insights

Mesenchymal stem cell-derived proteins show potential in treating osteosarcoma (OS) by inhibiting bone destruction. Activating specific pathways in stem cells enhanced their tumor-suppressing capabilities, offering a novel therapeutic avenue for this bone cancer.

Area of Science:

  • Oncology
  • Biotechnology
  • Regenerative Medicine

Background:

  • Osteosarcoma (OS) is a primary bone cancer predominantly affecting children and young adults.
  • Standard chemotherapy for OS has limitations, necessitating novel therapeutic strategies.
  • Mesenchymal stem cells (MSCs) and their secreted proteins are being explored for cancer therapy.

Purpose of the Study:

  • To investigate the potential of MSCs-derived proteomes and OS-elevated proteins as a protein-based therapy for osteosarcoma.
  • To evaluate the tumor-suppressing ability of MSCs-conditioned medium (CM) and modified MSCs (iTSCs).
  • To explore the therapeutic efficacy of CM in inhibiting tumor-induced bone destruction in a mouse model.

Main Methods:

  • Collected conditioned medium (CM) from MSCs and activated MSCs (iTSCs) via PKA activation.
  • Administered CM directly and via hydrogel in a mouse model of OS.
  • Analyzed protein enrichment in CM, including calreticulin (CALR) and PCOLCE.
  • Examined interactions between identified proteins (e.g., CALR with CD47, PCOLCE with amyloid precursor protein) and their expression in OS tissues.

Main Results:

  • MSCs-derived CM inhibited tumor-induced bone destruction in a mouse model, with additive effects when combined with cisplatin.
  • Activation of PKA converted MSCs into induced tumor-suppressing cells (iTSCs).
  • Calreticulin (CALR) and PCOLCE were identified as extracellular tumor suppressors in CM, with elevated CALR transcripts in OS tissues.
  • PCOLCE interacted with amyloid precursor protein, a poor prognostic marker in OS.

Conclusions:

  • MSCs-derived proteins, particularly calreticulin and PCOLCE, demonstrate extracellular tumor-suppressing activity against osteosarcoma.
  • A paradoxical strategy utilizing OS transcriptomes for treatment, potentially through engineered MSCs, is supported by these findings.
  • This study highlights the potential of protein-based therapies derived from stem cells and leveraging tumor-specific proteins for osteosarcoma treatment.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.8K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
7.6K
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
9.1K
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
5.2K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
5.0K